The FDA has published a notice announcing the availability of a draft guidance entitled “E16 Genomic Biomarkers Related to Drug Response: Context, Structure, and Format of Qualification Submissions.” The FDA is requesting comments on the guidance by September 28, 2009.
Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry